A Chief Pharmacy Officer must balance pharmacy operations, financial performance, and regulatory responsibilities. One area that deserves focused attention is orphan drug purchasing under the 340B Drug Pricing Program. Manufacturer discretionary pricing can change, making consistent monitoring important for identifying potential savings and avoiding outdated pricing assumptions. 340B Orphan...